Product category:
Lab automation equipment and robotics
News Release from: Caliper Life Sciences | Subject: Desktop Profiler
Edited by the Laboratorytalk Editorial
Team on 20 September 2006
Bench-top system helps qualify drug
candidates
Caliper Life Sciences has launched the Desktop Profiler, a bench-top system for kinase profiling, at the Society for Biomolecular Sciences (SBS) conference and exhibition in Seattle
Desktop Profiler enables therapeutic research laboratories to conduct in-house kinase profiling in a timely and cost-effective manner As biotech and pharmaceutical companies continue to explore the potential of kinases as viable drug targets, research scientists increasingly need to understand how drug candidates interact with the hundreds of different kinase enzymes present in the human body
This article was originally published on Laboratorytalk on 12 May 2008 at 8.00am (UK)
Related stories
Improve efficiency of solid phase extraction
Caliper Life Sciences has announced the availability of the Zephyr SPE Workstation, a benchtop solution designed to automate Solid Phase Extraction (SPE)
Cell-based GPCR profiling and lead optimisation
Caliper Life Sciences announces a collaboration with DiscoveRx that enables functional cell-based G protein-coupled receptor (GPCR) assays from DiscoveRx to be performed on Caliper's LabChip platforms
This kinase profiling is necessary to identifying potential side effects of therapeutic candidates.
Historically, cost constraints have limited the ability of therapeutic laboratories to conduct in-house profiling.
Desktop Profiler provides targeted research laboratories with a simple, affordable system to rapidly profile compounds against a diverse kinase panel.
To ensure ease-of-use, the Desktop Profiler works in conjunction with ProfilerPro kinase panel kits, also launched at SBS.
ProfilerPro microplates are pre-loaded with kinases, substrates and reagents, eliminating assay development and reducing experiment set-up time.
Additionally, the Desktop Profiler utilises Caliper's LabChip microfluidic-based screening technology to yield high-quality, reproducible data that helps researchers more confidently qualify drug candidates.
"The launch of the Desktop Profiler is an important part of our larger strategy to bridge in vitro and in vivo experimentation and enhance the clinical relevancy of drug discovery and development -- for all researchers," said Kevin Hrusovsky, president and CEO of Caliper Life Sciences.
"The Desktop Profiler generates meaningful in vitro data to identify drug candidates that won't drop out during in vivo studies".
The Desktop Profiler and ProfilerPro kinase panel profiling kits will be available in November.
The Desktop Profiler is currently on display at the 12th annual Society for Biomolecular Sciences conference and exhibition in Seattle. Request a free brochure from Caliper Life Sciences ...
• Caliper Life Sciences: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
